Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT03060720
Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy
Sponsor: Dana-Farber Cancer Institute
View on ClinicalTrials.gov
Summary
This research study is looking at people with cancer of the pancreas to find clinical factors that can explain the presence of genetic mutations
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
271
Start Date
2017-02-24
Completion Date
2028-02
Last Updated
2026-03-30
Healthy Volunteers
No
Conditions
Locations (1)
Dana Farber Cancer Institute
Boston, Massachusetts, United States